Matrix metalloproteinase 9 is associated with peritoneal membrane solute transport and induces angiogenesis through β-catenin signaling

Nephrology Dialysis Transplantation

Volumn 32, Issue 1, 2017, Pages 50-61

  Padwal, Manreet ^a   Siddique, Imad ^a   Wu, Lili ^b   Tang, Katelynn ^a   Boivin, Felix ^c   Liu, Limin ^a   Robertson, Jennifer ^c   Bridgewater, Darren ^c   West Mays, Judith ^c   Gangji, Azim ^a   Brimble, Kenneth Scott ^a   Margetts, Peter J ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

^b Beijing Institute of Chinese Medicine   (China)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Angiogenesis; Fibrosis; Matrix metalloproteinase; Peritoneal membrane; Transforming growth factor ; catenin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; BIOLOGICAL MARKER; GELATINASE B; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; CADHERIN; HEMODIALYSIS FLUID;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; MEMBRANE TRANSPORT; MESOTHELIUM CELL; MMP9 GENE; MOUSE; MYOFIBROBLAST; NONHUMAN; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PHENOTYPE; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENETICS; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BETA CATENIN; BIOLOGICAL TRANSPORT; CADHERINS; HEMODIALYSIS SOLUTIONS; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 85016172828     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfw076     Document Type: Article

References (54)

1. Margetts PJ, Brimble KS. Peritoneal dialysis, membranes and beyond. Curr Opin Nephrol Hypertens 2006; 15: 571-576
2. Williams JD, Craig KJ, Topley N et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479
3. Davies SJ. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 2004; 66: 2437-2445
4. Brimble KS, Walker M, Margetts PJ et al. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 2006; 17: 2591-2598
5. Aroeira LS, Aguilera A, Selgas R et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 2005; 46: 938-948
6. Margetts PJ, Bonniaud P, Liu L et al. Transient overexpression of TGF-b1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 2005; 16: 425-436
7. Chen YT, Chang YT, Pan SY et al. Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. J Am Soc Nephrol 2014; 25: 2847-2858
8. Catania JM, Chen G, Parrish AR. Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 2007; 292: F905-F911
9. Zhao XL, Sun T, Che N et al. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelialmesenchymal transition regulator Twist1. J CellMolMed 2011; 15: 691-700
10. Patel P,West-Mays J, KolbMet al. Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells. Matrix Biol 2010; 29: 97-106
11. Belotti D, Paganoni P, Manenti L et al. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 2003; 63: 5224-5229
12. Bauvois B. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. BiochimBiophys Acta 2012; 1825: 29-36
13. van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. CellMol Life Sci 2008; 65: 3756-3788
14. Korol A, Pino G, Dwivedi D et al. Matrix metalloproteinase-9-null mice are resistant to TGF-beta-induced anterior subcapsular cataract formation. Am J Pathol 2014; 184: 2001-2012
15. Qu B, Liu BR, Du YJ et al.Wnt/beta-catenin signaling pathwaymay regulate the expression of angiogenic growth factors in hepatocellular carcinoma. Oncol Lett 2014; 7: 1175-1178
16. Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 1989; 7: 95-108
17. Veldman-Jones MH, Brant R, Rooney C et al. Evaluating robustness and sensitivity of the nanostring technologies nCounter platform to enable multiplexed gene expression analysis of clinical samples. Cancer Res 2015; 75: 2587-2593
18. Ravanti L, Kahari VM. Matrix metalloproteinases in wound repair (review). Int JMolMed 2000; 6: 391-407
19. Sime PJ, Xing Z, Graham FL et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997; 100: 768-776
20. Leifler KS, Svensson S, Abrahamsson A et al. Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer. J Immunol 2013; 190: 4420-4430
21. Xing Z, Ohkawara Y, Jordana M et al. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J Clin Invest 1996; 97: 1102-1110
22. Kheradmand F, Rishi K, Werb Z. Signaling through the EGF receptor controls lungmorphogenesis in part by regulatingMT1-MMP-mediated activation of gelatinase A/MMP2. J Cell Sci 2002; 115(Pt 4): 839-848
23. Coussens LM, Tinkle CL, Hanahan D et al. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000; 103: 481-490
24. Sarin S, Boivin F, Li A et al. beta-Catenin overexpression in the metanephric mesenchyme leads to renal dysplasia genesis via cell-autonomous and noncell-autonomousmechanisms. Am J Pathol 2014; 184: 1395-1410
25. Emami KH, Nguyen C, Ma H et al. A small molecule inhibitor of betacatenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci USA 2004; 101: 12682-12687
26. NumataM, NakayamaM, Nimura S et al. Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate. Perit Dial Int 2003; 23: 116-122
27. Barreto DL, Coester AM, Struijk DG et al. Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients? Perit Dial Int 2013; 33: 529-537
28. Barreto DL, Struijk DG, Krediet RT. Peritoneal effluent MMP-2 and PAI-1 in encapsulating peritoneal sclerosis. Am J Kidney Dis 2015; 65: 748-753
29. Cho Y, Johnson DW, Vesey DA et al. Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients. BMC Nephrol 2014; 15: 8-15
30. Hirahara I, Inoue M, Okuda K et al. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis-a multicentre study in Japan. Nephrol Dial Transplant 2007; 22: 560-567
31. Hirahara I, Ogawa Y, Kusano E et al. Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats. Nephrol Dial Transplant 2004; 19: 1732-1741
32. Zheng G, Lyons JG, Tan TK et al. Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. Am J Pathol 2009; 175: 580-591
33. Symowicz J, Adley BP, Gleason KJ et al. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Res 2007; 67: 2030-2039
34. Mei JM, Borchert GL, Donald SP et al. Matrix metalloproteinase(s) mediate( s) NO-induced dissociation of beta-catenin from membrane bound Ecadherin and formation of nuclear beta-catenin/LEF-1 complex. Carcinogenesis 2002; 23: 2119-2122
35. Dwivedi A, Slater SC, George SJ. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation. Cardiovasc Res 2009; 81: 178-186
36. Yamashita CM, Dolgonos L, Zemans RL et al. Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis. Am J Pathol 2011; 179: 1733-1745
37. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009; 17: 9-26
38. Mira E, Lacalle RA, Buesa JM et al. Secreted MMP9 promotes angiogenesis more efficiently than constitutive activeMMP9 bound to the tumor cell surface. J Cell Sci 2004; 117(Pt 9): 1847-1857
39. Heissig B, Rafii S, Akiyama H et al. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J ExpMed 2005; 202: 739-750
40. Bendeck MP. Macrophage matrix metalloproteinase-9 regulates angiogenesis in ischemicmuscle. Circ Res 2004; 94: 138-139
41. van Hinsbergh VW, Koolwijk P. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res 2008; 78: 203-212
42. Patel P, Sekiguchi Y, Oh KH et al. Smad3-dependent and -independent pathways are involved in peritoneal membrane injury. Kidney Int 2010; 77: 319-328
43. Tian X, Zhang J, Tan TK et al. Association of beta-catenin with P-Smad3 but not LEF-1 dissociates in vitro profibrotic from anti-inflammatory effects of TGF-beta1. J Cell Sci 2013; 126(Pt 1): 67-76
44. Tan TK, Zheng G, Hsu TT et al. Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage. Lab Invest 2013; 93: 434-449
45. Zhao H, Dong Y, Tian X et al. Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases.World J Nephrol 2013; 2: 84-89
46. Fielding CA, Jones GW, McLoughlin RM et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity 2014; 40: 40-50
47. Humphreys BD, Lin SL, Kobayashi A et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85-97
48. Wu CF, Chiang WC, Lai CF et al. Transforming growth factor beta-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis. Am J Pathol 2013; 182: 118-131
49. Pardo A, Selman M. Role of matrix metaloproteases in idiopathic pulmonary fibrosis. Fibrogenesis Tissue Repair 2012; 5(Suppl 1): S9
50. Tan TK, Zheng G, Hsu TT et al. Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells. Am J Pathol 2010; 176: 1256-1270
51. Riches K, Morley ME, Turner NA et al. Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts. J Mol Cell Cardiol 2009; 47: 391-399
52. Zhao S, Ma W, Zhang M et al. High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients.Med Oncol 2013; 30: 335
53. Joseph MJ, Dangi-Garimella S, Shields MA et al. Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells. J Cell Biochem 2009; 108: 726-736
54. Sabeh F, Li XY, Saunders TL et al. Secreted versus membrane-anchored collagenases: relative roles in fibroblast-dependent collagenolysis and invasion. J Biol Chem 2009; 284: 23001-23011